The AVCO balloon pump has been employed in treating 40 patients with cardiogenie shock from acute myocardial infarction (CS-MtI). All patients were given a trial of medical therapy with hemodynamic monitoring. The time from the development of shock to institution of intraaortic balloon pumping (IABP) was less than 24 hours in all but nine patients. Prior to IABP the mean hemodynamic values were: cardiac index (CI) 1.7 liters/min/M2; mean arterial pressure (MAP) 66 mm Hg; pulmonary artery wedge pressure (PAW) 22 mm Hg. After 24-48 hours of IABP the CI and MAP had increased 0.8 liters/min/2M and 8 mm Hg, respectively, and the PAW had decreased 4.8 mm Hg. During IABP the shock syndrome was reversed in 31 patients. Four of 25 patients treated with IABP alone survived to be discharged, but two have died from subsequent infaretions. Because of the persistent high mortality, 15 patients judged unable to survive off IABP have undergone emergency surgical procedures with IABP continuing during preoperative angiography and postoperatively. Six were long-term survivors. It is concluded: (1) IABP is a safe, effective means of supporting the circulation in CS-MI; (2) IABP alone will improve survival in some patients; (3) IABP can provide circulatory support during angiography and the perioperative period in patients requiring revascularization for survival; and (4) some patients with CS-MI have myocardial necrosis too extensive to permit survival without permanent circulatory assistance or total cardiac replacement.
DUNKMAN ET AL. This paper reports our experience in treating 40 patients with IABP for CS-MI in whom serial hemodynamic measurements are available to assess the effectiveness of balloon pumping alone and balloon pumping combined with revascularization surgery.
Materials and Methods
The 40 patients in this series were referred from the coronary care units of the Massachusetts General Hospital and other hospitals during the period from November 1968 to May 1971. These patients had historical, electrocardiographic, and enzymatic evidence of acute myocardial infarction and appeared to be in cardiogenic shock with decreased peripheral pulses, cool skin, a systolic pressure usually under 90 mm Hg, varying degrees of mental obtundation, and a urine output less than 20 ml/hour. The patients were transferred to the intensive study area of the Myocardial Infaretion Research Unit, an area equipped with a radiolucent bed, portable image-intensifier fluoroscope, and multichannel analog system for recording pressure and cardiac output. The monitoring format included (mr 2 
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PUtLMOVARYARTERY WEDGE cc nHg) WO r 0 an indwelling radial or femoral arterial cannula, a central venous pressure line, and in the latter 24 patients a Swan-Ganz flow-directed pulmonary artery catheter. 7, 8 Cardiac outputs were performed with the indocyanine green (Cardiogreen) dye-dilution technic, injecting 7 mg into the pulmonary artery and sampling through the radial or femoral cannula using a Gilford model 103 densitometer and Lexington model COCS cardiac output computer. IABP was performed with the AVCO intraaortic balloon pump using technics previously described.A" The balloon inflation and deflation is regulated from a surface-monitored ECG. Inflation can be adjusted to occur at any time during the first 20-50% of the R-R interval and deflation during the latter 50% of the R-R interval. In general, balloon inflation was timed to occur shortly after the peak of the T-wave and deflation late in the following P-R interval. Final adjustment was made to produce a radial arterial pressure curve resembling that depicted in the third panel of figure 1 , with inflation on the dicrotic notch and deflation prior to the ascending limb but late enough to produce an end-diastolic pressure approximating that off IABP. Femoral cannulae were not used to make the final timing 
Figure 1
Effect of reinstitution of IABP in a representative patient in whom the shock syndrome had been reversed by a previous period of pumping. In the center panel the paper speed has been slowed. Resumption of pumping resulted in a decrease in systolic pressure (S) of 20 mm Hg and an increase in peak diastolic pressure (D) of 45 mm Hg. The mean arterial pressure was unchanged. Note the immediate fall in the mean pulmonary artery wedge pressure from 25 to 18 mm Hg. adjustment because the balloon pressure is transmitted to the monitoring site sooner than is the left ventricular pressure.
Systemic and pulmonary arterial pressures were monitored continuously during IABP, and cardiac output measurements were performed in duplicate once or twice daily. Duplicate output determinations usually agreed well within 10%. When greater variation was seen, additional determinations were made until such agreement was obtained. During IABP, heparin was administered intravenously as a bolus every 4 hours to keep the partial thromboplastin time (PTT) at 40-60 sec at 3X hours after each dose, and low molecular-weight dextran (Rheomacrodex) was given intravenously at 10 cc/hour. Arterial blood gases and PTT were determined every 4 hours; hematocrit and platelet counts every 12 hours; white blood count and differential count, reticulocyte count, serum hemoglobin, prothrombin time, fibrinogen, BUN, bilirubin, alkaline phosphatase, SGOT, LDH, CPK, ECG, and portable chest film daily.
Patients selected for IABP had a mean age of 55 years (range 38-81 years; only one patient was over 68 years of age). The site of myocardial infarction, the time of onset of shock after infarction, and the time of institution of IABP after the onset of shock are shown in table 1. All patients were given a trial of medical therapy directed at the correction of hypoxia, acidosis, arrhythmias, and hypovolemia, including moderate doses of catecholamines.
Twenty patients judged unable to survive if IABP were withdrawn underwent left ventricular and selective coronary angiography with IABP continuing during the study. The criteria for angiography were: (1) failure to improve significantly after 12-24 hours of IABP and catecholamine infusion; (2) continued high or increasing (3) refractory pump failure more than 1 week after myocardial infarction; and (4) balloon dependence after 48 hours of assistance. Balloon dependence was diagnosed when the cardiac index fell to less than 2.0 liters/min/m2, the mean arterial pressure fell to less than 60 mm Hg, and the pulmonary artery wedge pressure rose to greater than 20 mm Hg in the "on-off" study or after 12 hours of reduced circulatory assistance. Fifteen of these patients had emergency surgery performed with balloon support during surgery and the immediate postoperative period. Details of surgery are reported elsewhere.9 10 Two patients had infarctectomy alone, and 13 had coronary artery bypass grafting of one to three vessels. Of those who had bypass grafting, eight also had infarctectomies and two had mitral valve replacement. In one case cardiogenic shock was secondary to severe mitral regurgitation and in another, refractory ventricular arrhythmias. Postmortem examination of the hearts was performed by a technic described elsewhere.'
Results
Hemodynamic values at the initiation of IABP were (mean + SD): cardiac index (CI) 1.7 + 0.5 liters/min/m2; mean arterial pressure (MAP) 66 + 11 mm Hg; and pulmonary artery wedge pressure (PAW) 22 ± 5 mm Hg. The clinical response to IABP was usually impressive, with the shock syndrome being reversed in 31 of the 40 patients. Table 2 lists the individual results.
Hemodynamic Response
The effect of IABP on cardiovascular dynamics in best described in four parts: (1) the initial effects; (2) the peak improvement on IABP; (3) the acute effect of cessation of IABP; and (4) the ability to maintain improvemenit after withdrawal of the balloon.
Initial Effects
Significant improvement in the clinical status of patients usually occurred withini 1-2 hours of the institution of IABP; obtundation cleared, the patient's sense of well being was restored, and diuretic responsiveness returned. An example of the capability of IABP to produce prompt improvement is shown in figure 2. The peak improvement on IABP occurred after a mean of 25 hours (range 1-90 hours). During this time there was a significant increase in CI and MAP and a decrease in PAW. The magnitude of these effects is shown in table 2 and figure 3. The decrease in PAW of 4.8 mm Hg was less than could have been achieved but resulted because the wedge pressure was maintained at 17-19 mm Hg with albumin or fluid infusions in order to maximize the Starling effect on cardiac output, while avoiding high pressures which often result in pulmonary edema.
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In the nine patients (22.5%) in whom the shock syndrome was hot reversed by IABP Efect of institution of IABP on radial artery pressure. In the center of the panel, the pap)er speed has been changed from 0.5 to 25 mm/sec. With IABP there was a prompt increase in pulse pressure from 10 to 45 mm Hg. The resultant peak (diastolic) pressure was 70 mm Hg.
(table 2, asterisks), the CI on IABP did not reach 2.0 liters/min/m2 and the BUN continued to rise. Eight of the nine patients died within 48 hours of initiation of IABP and the ninth, in whom shock was due to recurrent ventricular arrhythmias (table 2, patient 39), underwent infaretectomy and was a long-term survivor.
Acute Effect of IABP After IABP was underway, the contribution of pumping to the hemodynamic status was measured once or twice daily by an "on-offon" study. This was achieved by recording the systemic and pulmonary arterial wedge pressures followed by the determination of cardiac output. Pumping was then interrupted; 3-60 min were then allowed to elapse during which the pressures were monitored closely and the Ctrculation, Volume XLVI, September 1972 clinical state observed. Signs of restlessness, dyspnea, and diaphoresis, or excessive deterioration of pressures ended the trial period. Before resuming the IABP another cardiac output was determined. Then, S min after the reinstitution of IABP, measurement of pressures and cardiac output was repeated. When the balloon was in place, pumping was never discontinued for more than 60 min in order to avoid clot formation in the interstices of the collapsed balloon.
The mean contribution of pumping measured in this way was a significant increase in CI and MAP and a decrease in PAW. The magnitude of these effects after an average of 21 hours of IABP is shown in figure 4 . Data for each patient were taken from the day on which maximal differences were observed and are shown in table 3 . After resumption of 469 DUNKMAN ET AL. The peak improvement in hemodynamic values in 40 patients after a mean of 25 hours of IABP. The CI increased 0.8 liters/min/m2 and the MAP 8 mm Hg. The mean PAW decreased 4.8 mm Hg. All changes are significant at P < 0.001. IABP the MAP and CI tended to be higher and the PAW lower than those prior to cessation, presumably secondary to the summation of effects of IABP and the residue of compensatory mechanisms activated when IABP was interrupted; thus measurements prior to the cessation of IABP are probably more representative of the average hemodynamic status of the patient and were used in calculating the data for figure 4 . In many instances, the arterial p02 decreased when IABP was discontinued, sometimes by 50%. Occasionally discontinuing pumping resulted in anginal pain, restlessness, or arrhythmias. The effect of reinstitution of pumping in a representative patient is shown in figure 1. Figure 5 shows daily "on-off" studies for a representative patient assembled into one graph. Of the 25 patients who survived long enough for such a graph to be constructed, 23 followed the pattern illustrated in figure 5 ; namely, a cumulative improvement in hemodynamic values both on and off IABP for 24-72 hours, followed by a deterioration which occurred even with continued IABP.
Ability to Maintain Improvement after Withdrawal of Balloon
The final measure of the hemodynamic response to IABP was the effect of its withdrawal. Serious hemodynamic deterioration often was not apparent in an hour-long "on-off" study, but was measurable after 12-24 hours off IABP. Therefore, a period of diminished circulatory assistance, achieved either by decreasing the volume of inflation (with full inflation for 5 min of each hour) or by decreasing the frequency of inflation with full volume was devised. Survivors had a CI of 2.1 liters/min/m2 or greater, an MAP of 65 mm Hg or greater, and a PAW pressure of 20 mm Hg or lower after 12-24 hours of reduced C. circulatory assistance. There were four nonsurvivors who met these criteria. Three died suddenly on the 34th, 36th, and 40th day, respectively, after balloon removal, and the fourth of pneumonia 11 days after balloon removal. In a fifth patient, treated before these criteria were developed, the balloon was removed after 90 hours of pumping, at which time the CI was 2.7 liters/min/m2 off IABP.
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Twenty hours after balloon removal the cardiac index had fallen to 1.6 liters/min/m2. Nevertheless, the patient survived 30 days, but in a low-output state which required intensive management of fluid intake and diuretics.
Effect on Mortality
The effect on mortality is shown in figure 6 . Of 25 patients treated with IABP alone, 12 471 DUNKMAN ET AL. Daily cardiac indices on IABP and after acute cessation of IABP in patient A.S. The peak index on IABP is indicated by point B. The peak improvement on IABP is therefore represented by the change from point A to B. The maximal acute effect is the difference between points B and C. Note the rise in index for 48 hours with deterioration after 72 hours, despite continued IABP. died while on IABP, five with the shock state unreversed and seven due to arrhythmias or redevelopment of shock despite IABP. Four died within a week of termination of IABP. Nine were successfully weaned from IABP, although five died before discharge at a mean of 30 days after removal of the balloon. Four patients (16%) survived to be discharged. Two of these four sustained subsequent infarctions 3 days and 15 months respectively, after discharge, were readmitted, underwent IABP, angiography, and surgery, but expired. Two are living at 21 and 30 months and have satisfactory exercise tolerance.
Of the 15 patients who underwent emergency surgical procedures, the shock state had not been reversed by IABP in four. Six of the 15 (40%) were long-term survivors. Two late deaths occurred, one at 2 months from intraabdominal bleeding despite three laporotomies and one at 4 months at another hospital from congestive failure. Four are living and asymptomatic at 8-16 months. Among the survivors, one had infarctectomy alone (for refractory ventricular arrhythmias) and five had coronary artery bypass grafts. Of those who had bypass grafting, two received left anterior descending and right coronary artery grafts, one a right coronary artery graft With the exception of the patient whose shock was secondary to refractory ventricular arrhythmias, no patient in whom the shock syndrome was not reversed by IABP survived, whether or not surgery was performed. Three of the four patients who survived with IABP alone experienced shock within 7 hours of their infarction and all underwent IABP within 9 hours of the onset of shock. In those who survived with the aid of surgery, shock developed 20 hours to 22 days after infarction and IABP was instituted as late as 72 hours after the onset of shock. There was no significant difference in duration of IABP between survivors and nonsurvivors, with or without surgery. The mean duration of IABP for all patients was 86 hours, with a maximum duration of 330 hours.
Pathologic Correlations
Autopsies were performed on 21 of the 30 patients who died. All but four had necrosis of 40% or more of the left ventricular myocardium. Two of the patients with less than 40% necrosis had complicating pseudomonas pneumonia. The other two died from arrhythmia and unsuccessful surgery, respectively. These observations are consistent with the data reported elsewhere" that the majority of patients dying in cardiogenic shock have extensive myocardial necrosis.
Complications of Therapy
Pulmonary Artery Catheters
The Swan-Ganz catheter was frequently left in place for 1 week or longer without embolic or septic complications. In one case the catheter migrated to a wedge position and fluid infusion was inadvertently continued. A pulmonary infarct resulted which cavitated but eventually resolved completely.
The Balloon IABP has resulted in four complications. The first was a variable degree of vascular insufficiency in the catheterized limb after Circulation, Volume XLVI, September 1972 removal of the balloon. In no case was reexploration necessary or loss of limb experienced. Recently routine Fogarty catheter exploration of the catheterized vessels at the time of removal of the balloon has been performed with recovery of clots and reduction in incidence and severity of vascular insufficiency. In one patient in whom autopsy permitted examination of the site of balloon insertion, there was evidence that the graft through which the balloon was introduced had been oversewn too securely. The second complication was dissection of the aorta by the balloon catheter during its introduction which was discovered in two cases at autopsy. In one case the balloon entered the arterial wall at the site of a plaque in the common iliac artery and was completely within a false lumen. The effectiveness of IABP in this instance was not diminished. In the second case, the superior part of the balloon catheter created a false lumen for 3-4 cm in the descending aorta and then reentered the aortic lumen. This probably restricted inflation of the superior segment of the balloon, and slightly decreased effectiveness of IABP was noted. In neither case did the dissection produce clinically detectable symptoms or signs. The third complication was the finding of two small emboli, one testicular and one renal, at autopsy. However, there has been no clinical evidence of peripheral embolization. The final complication of IABP was a moderate reduction in the platelet count during pumping. Following the previously reported case of thrombocytopenia on IABP,3 patients were treated with dextran as well as heparin. Approximately half of the patients showed a fall in platelet count to 50% of the pre-IABP level in the first 60 hours of pumping.12 In half the patients who demonstrated a fall, the platelet count remained depressed, while in the remainder the platelet count rose as IABP continued. Postoperative patients did not receive heparin but were treated with dextran and had mean platelet counts lower than nonsurgical patients'2 but not lower than commonly seen after cardiopulmonary bypass alone. In no case did 473 thrombocytopenia cause clinically significant bleeding or require termination of IABP.
There has been one case of proved consumption coagulopathy (platelets 33,000/mm3, fibrinogen 100 mg%, Fi test positive at 1:258) which was effectively treated with increased heparin doses and did not require removal of the balloon. The shock state, a known cause of consumption coagulopathy,13, 14 was considered to be responsible for the coagulopathy in this case.
Guaiac-positive stools and hematuria occasionally occurred, probably as a result of heparinization, but these were not significant clinical problems. Serum hemoglobin determinations during IABP were typically modestly elevated, the average equilibrium level being 23 mg% (range 4.8-88.8 mg%) .12 No renal damage was attributable to this degree of hemoglobinemia.
Discussion
The present data are consistent with pathologic observations11 that cardiogenic shock is the result of loss of functioning left ventricular myocardium beyond a critical mass necessary to support essential circulation. If untreated, a self-perpetuating cycle ensues ( fig. 7) , with systemic hypotension and acidosis, decreased coronary blood flow, myocardial hypoxia, and arrhythmias further impairing myocardial performance and causing additional necrosis in areas adjacent to the initial infaretion secondary to the original coronary event and in remote areas secondary to shock. The result is Self-perpetuating cycles in cardiogenic shock. a mortality approaching 100% despite the use of catecholamines, diuretics, respiratory assistance, and modern pacing technics. Indeed, forms of therapy which increase myocardial oxygen demand without increasing coronary blood flow may increase the extent of myocardial dysfunction and necrosis.15 ' 16 In contrast, the data reported here offer clinical support to the concept that IABP is capable of interdicting the vicious cycle, reducing left ventricular work by decreasing left ventricular systolic pressure,17 increasing blood flow to pressure-dependent areas of myocardium by increasing aortic diastolic pressure, and improving peripheral perfusion through the resultant increase in cardiac output. 6 18,19 Thus, a critical margin of left ventricular myocardium may be preserved.20
Before 24-48 hours of IABP had elapsed, these 40 patients initially in cardiogenic shock had separated into three basic groups. First, some made such substantial gains that IABP could eventually be discontinued without a marked clinical or hemodynamic deterioration. Their CI remained 2.1 liters/min/m2 or greater, MAP 65 mm Hg or more, and PAW 20 mm Hg or less after acute cessation of IABP and after 12 hours of reduced circulatory assistance. Individuals in this group often survived to be discharged without surgery. While the maximum infarct size compatible with this clinical course in unknown, it is clear that in this group infarcts may not be extensive. We have attempted to exclude from this series those who would survive without circulatory assistance by making failure to respond to conventional medical therapy a criterion for IABP. Two patients in the series were discharged with minimal limitation and with a normal heart size. Such a result almost certainly indicates that their cardiogenic shock was largely a result of reversible myocardial dysfunction and that IABP, either by providing increased coronary perfusion pressure or by allowing shock support without catecholamine stimulation, helped preserve myocardium. Second, nine patients showed insignificant gains during IABP and catecholamine infusion Circulation, Volume XLVI, September 1972 474 INTRAAORTIC BALLOON PUMPING (table 2, asterisks). Postmortem examination in five of these patients showed either infarction exceeding 40% of the left ventricle or irreparably severe trivessel disease. We have had no success with this group whether or not surgery was performed, with the exception of one operative survivor whose shock was secondary to refractory ventricular tachycardia and fibrillation. It is suggested but not proven that patients who remain in shock in spite of IABP after rhythm and metabolic corrections usually have irreversibly fatal disease.
Third, the majority responded to IABP with resolution of shock but remained balloon dependent. Before February 1970, when angiograms were not done, such patients were weaned from IABP nonetheless, with the aid of diuretics and reinstituted catecholamine infusions. This accounts for the high death rate after balloon removal but before discharge. With angiographic and operative experience, it became apparent that this third group could be subdivided into those who were balloon dependent because of too large an infarction and those who were dependent because of a combination of infarction and persistent reversible ischemia. The ischemic group could greatly benefit from emergency revascularization.
In retrospect, these groupings could not be predicted by the patients' initial medical appearance or hemodynamic state. Moreover, the peak hemodynamic response to IABP was not always of prognostic significance because of the as yet unexplained hemodynamic deterioration which often occurred even with continued pumping. Nevertheless, IABP was the standard intervention against which patient response could be measured. Those who did not respond to IABP had lesions too extensive to repair, and those who remained balloon dependent could be angiographically evaluated with continued balloon support.
The angiogram remained the best means for separating those who were balloon dependent because of extensive infarction from those who were dependent because of a combination of infarction and persistent ischemia.
Circulation, Volume XLVI, September 1972 Details of the distinction are described elsewhere. 22 The separation was often poor, and until an adequate method for determining infarct size is available it appears that the selection of patients for operation will remain somewhat uncertain.
Patients with shock secondary to acute ventricular septal defects, severe mitral regurgitation, or arrhythmia after acute myocardial infarction form a group different from those discussed above, as shock may be due to a mechanical abnormality other than extensive loss of left ventricular myocardium. Based on the experience reported here, IABP is effective in this group and surgery may produce excellent results. 23 Complications of IABP were few in this series. The decreases in platelet count which have been observed have not been clinically important. Moreover, platelet levels in CS-MI without IABP have not been adequately studied to allow firm conclusions to be drawn regarding the effect of IABP alone on platelets. While two small emboli were observed in this series, clinically significant arterial embolization was not observed. This may be attributable to the practice of nearly continuous pumping while the balloon catheter is in place. The two aortic dissections in this series were asymptomatic. Nevertheless, in this group of patients who may show severe aortoiliac atherosclerosis, serious aortic trauma produced during balloon insertion remains the greatest potential hazard.
Based on the current experience, IABP is the treatment of choice for cardiogenic shock following myocardial infarction not promptly responsive to medical management. Its effectiveness in reversing the shock syndrome, decreasing left ventricular work, and its potential for increasing collateral coronary blood flow and conserving myocardial tissue make it a physiologically sound mode of therapy. In addition, the progressive myocardial necrosis accompanying the shock state argues for the early application of IABP in CS-MI.
It is concluded: (1) IABP is a safe and effective means of supporting the circulation 475 in CS-MI. (2) IABP alone may effect survival in some patients. (3) IABP can provide essential circulatory support during hemodynamic evaluation, angiography, and the postoperative period in patients requiring revascularization for survival. (4) Some patients with CS-MI have myocardial necrosis too extensive to permit survival without permanent circulatory assistance of total cardiac replacement.
